SEC - The United States Securities and Exchange Commission

08/22/2024 | Press release | Distributed by Public on 08/22/2024 13:23

Administrative Proceedings (Valeant Pharmaceuticals International, Inc. n/k/a Bausch Health Companies Inc.; J. Michael Pearson; Howard B. Schiller; and Tanya R. Carro, CPA)